Adaptin Bio, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Adaptin Bio, Inc. (APTN) had Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $50.39 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-04-15
- Adaptin Bio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $29.59K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2024-12-31 | $50.39K 10-K · filed 2025-04-15 | |
| 2023-12-31 | $29.59K 10-K · filed 2024-04-01 |